Search Results - "LADD, SHARRON"

Modulation of hyaluronan production by CD44 positive glioma cells by Wiranowska, Marzenna, Ladd, Sharron, Moscinski, Lynn C., Hill, Bobbye, Haller, Ed, Mikecz, Katalin, Plaas, Anna

“…This study examines the functional relationship between glioma cell production of hyaluronan (HA), known to play a role in glioma invasion, expression of its…”
Get full text

CD44 adhesion molecule and neuro-glial proteoglycan NG2 as invasive markers of glioma by Wiranowska, Marzenna, Ladd, Sharron, Smith, Sarice R., Gottschall, Paul E.

Get full text

Comparison of MART‐1 Frozen Sections to Permanent Sections Using a Rapid 19‐Minute Protocol by CHERPELIS, BASIL S., MOORE, RICHARD, LADD, SHARRON, CHEN, REN, FRANK GLASS, L.

“…BACKGROUND The use of melanoma‐associated antigen recognized by T cells (MART‐1) immunostain has been proposed as a useful adjunct to overcome the inherent…”
Get full text

A phase I, first-in-human study to evaluate the safety, pharmacokinetics (PK), and pharmacodynamics (PD) of IMGN853 in patients (Pts) with epithelial ovarian cancer (EOC) and other FOLR1-positive solid tumors by Kurkjian, Carla, LoRusso, Patricia, Sankhala, Kamalesh Kumar, Birrer, Michael J., Kirby, Maurice, Ladd, Sharron, Hawes, Susan, Running, Kelli Lynn, O'Leary, James J., Moore, Kathleen N.

“…Abstract only 2573 Background: IMGN853 is an antibody-drug conjugate (ADC) comprising a folate receptor 1 (FOLR1)-binding antibody and the potent maytansinoid,…”
Get full text

Scoring of Mohs Tissue in One‐Piece Processing to Prevent Tissue Crumbling or Detachment from the Embedding Medium While Sectioning by LADD, SHARRON, CHERPELIS, BASIL S.

Get full text

Immunohistochemical Stains in Mohs Surgery: A Review by STRANAHAN, DONALD, CHERPELIS, BASIL S., GLASS, L. FRANK, LADD, SHARRON, FENSKE, NEIL A.

“…BACKGROUND During Mohs surgery, there are instances in which residual tumor cells may be difficult to detect, thereby increasing the risk of incomplete…”
Get full text

Phase I Study of Lorvotuzumab Mertansine (LM, IMGN901) in Combination with Lenalidomide (Len) and Dexamethasone (Dex) in Patients with CD56-Positive Relapsed or Relapsed/Refractory Multiple Myeloma (MM) by Berdeja, Jesus G., Hernandez-Ilizaliturri, Francisco, Chanan-Khan, Asher, Patel, Manish, Kelly, Kevin R., Running, Kelli L., Murphy, Mary, Guild, Robin, Carrigan, Christina, Ladd, Sharron, Wolf, Beni B., O'Leary, James J., Ailawadhi, Sikander

“…Abstract 728 LM, an antibody-drug conjugate (ADC), is designed to specifically kill CD56+ cancer cells and contains a potent maytansinoid cytotoxic agent (DM1)…”
Get full text

Innovative 19‐Minute Rapid Cytokeratin Immunostaining of Nonmelanoma Skin Cancer in Mohs Micrographic Surgery by CHERPELIS, BASIL S., TURNER, LOGAN, LADD, SHARRON, GLASS, L. FRANK, FENSKE, NEIL A.

“…BACKGROUND Dense inflammation can obscure nonmelanoma skin cancer (NMSC) on frozen sections, prompting removal of additional layers to ensure negative margins…”
Get full text

Rapid Frozen Section Immunostaining of Melanocytes by Microphthalmia-Associated Transcription Factor by GLASS, L. Frank, RAZIANO, Renata M, CLARK, Graham S, HIGGINS, H. William, LADD, Sharron, LIEN, Mary H, REN CHEN, CHERPELIS, Basil S

“…Mohs micrographic surgery (MMS) has increasingly become an accepted therapy for melanoma in situ on chronically sun damaged skin (CSDS). However, melanocytes…”
Get full text

Mohs surgery for melanoma in situ: how we do it by Cherpelis, Basil S, Glass, L Frank, Ladd, Sharron, Fenske, Neil Alan

“…The advent of rapid immunostains has made the use of Mohs surgery to treat melanoma more practical. Mohs surgery is especially useful in the management of…”
Get more information

CD44 adhesion molecule and neuro-glial proteoglycan NG2 as invasive markers of glioma by Wiranowska, Marzenna, Ladd, Sharron, Smith, Sarice R, Gottschall, Paul E

“…Glioma invasion into the CNS involves the interaction of tumor cells with the host's cells and extracellular matrix (ECM) molecules. In this study, the…”
Get full text